Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 318, 94-100
Abstract
No abstract availableKeywords
Funding Information
- European Union's Horizon 2020 (777204)
This publication has 19 references indexed in Scilit:
- Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargementJournal of Cardiovascular Medicine, 2017
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2016
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- The Global Health and Economic Burden of Hospitalizations for Heart FailureJACC, 2014
- Psychological Stress and 30-Day All-Cause Hospital Readmission in Acute Coronary Syndrome Patients: An Observational Cohort StudyPLOS ONE, 2014
- Prognostic Significance of Myocardial Fibrosis in Hypertrophic CardiomyopathyJACC, 2010
- Left Atrial Volume Index: A Predictor of Adverse Outcome in Patients With Hypertrophic CardiomyopathyJournal of the American Society of Echocardiography, 2009
- Repeated hospitalizations predict mortality in the community population with heart failureAmerican Heart Journal, 2007
- Historical trends in reported survival rates in patients with hypertrophic cardiomyopathyHeart, 2005